Kornitzer Capital Management Inc. KS Decreases Holdings in Azenta, Inc. (NASDAQ:AZTA)

Kornitzer Capital Management Inc. KS reduced its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 37.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 75,241 shares of the company's stock after selling 45,000 shares during the quarter. Kornitzer Capital Management Inc. KS owned about 0.14% of Azenta worth $4,901,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of AZTA. Federated Hermes Inc. grew its holdings in Azenta by 29.2% in the 4th quarter. Federated Hermes Inc. now owns 365,506 shares of the company's stock valued at $23,809,000 after buying an additional 82,502 shares in the last quarter. Lecap Asset Management Ltd. bought a new stake in Azenta in the 4th quarter valued at about $319,000. Louisiana State Employees Retirement System bought a new stake in Azenta in the 4th quarter valued at about $1,101,000. Cerity Partners LLC acquired a new position in Azenta in the 4th quarter valued at $322,000. Finally, Conestoga Capital Advisors LLC raised its holdings in Azenta by 13.4% in the 4th quarter. Conestoga Capital Advisors LLC now owns 1,291,284 shares of the company's stock valued at $84,114,000 after acquiring an additional 152,090 shares in the last quarter. 99.08% of the stock is owned by institutional investors.

Azenta Stock Up 0.3 %

Shares of AZTA stock traded up $0.16 on Friday, reaching $50.65. The company had a trading volume of 436,782 shares, compared to its average volume of 394,702. The business's 50-day moving average is $60.68 and its 200 day moving average is $59.05. The stock has a market capitalization of $2.82 billion, a PE ratio of -163.38 and a beta of 1.53. Azenta, Inc. has a one year low of $36.01 and a one year high of $69.16.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The company had revenue of $154.32 million during the quarter, compared to the consensus estimate of $151.86 million. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. On average, sell-side analysts forecast that Azenta, Inc. will post 0.27 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AZTA has been the subject of several analyst reports. Jefferies Financial Group initiated coverage on Azenta in a report on Thursday, April 4th. They issued a "hold" rating and a $64.00 price objective for the company. Evercore ISI decreased their target price on shares of Azenta from $64.00 to $60.00 and set an "in-line" rating on the stock in a report on Thursday, April 4th. Needham & Company LLC reissued a "buy" rating and issued a $75.00 target price on shares of Azenta in a report on Monday, April 8th. Stephens reissued an "equal weight" rating and issued a $70.00 target price on shares of Azenta in a report on Thursday, February 8th. Finally, B. Riley raised their target price on Azenta from $61.00 to $79.00 and gave the company a "buy" rating in a report on Thursday, February 1st. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Azenta presently has an average rating of "Hold" and an average price target of $69.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.